GSE163282 aspirin 12 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE163282_aspirin_12_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE163282_aspirin_12_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE163282_aspirin_12_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE163282_aspirin_12_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 86, member C

Gene

long intergenic non-protein coding RNA 865

Gene

long intergenic non-protein coding RNA 1508

Gene

cancer/testis associated 62

Gene

small nucleolar RNA host gene 31

Gene

SPATA3 antisense RNA 1

Gene

NOVA1 divergent transcript

Gene

CPVL antisense RNA 2

Gene

NQO2 antisense RNA 1

Gene

uncharacterized LOC105374041

  • Gene

    family with sequence similarity 86, member C


  • Gene

    long intergenic non-protein coding RNA 865


  • Gene

    long intergenic non-protein coding RNA 1508


  • Gene

    cancer/testis associated 62


  • Gene

    small nucleolar RNA host gene 31


  • Gene

    SPATA3 antisense RNA 1


  • Gene

    NOVA1 divergent transcript


  • Gene

    CPVL antisense RNA 2


  • Gene

    NQO2 antisense RNA 1


  • Gene

    uncharacterized LOC105374041

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.